2.490 s

-0.160 (-6.04%)
Range 1.935 - 2.520   (30.23%)
Open 2.370
Previous Close 2.650
Bid Price 0.650
Bid Volume 32
Ask Price 0.678
Ask Volume 10
Volume 566,976
Value -
Remark s
Delayed prices. Updated at 04 May 2024 04:00.
Data powered by
View All Events

About CYCLACEL PHARMACEUTICALS INC

Cyclacel Pharmaceuticals, Inc. develops therapies that harness the power of the immune system to treat cancer and other serious illnesses. The Company develops proprietary techniques of antibody engineering to develop antibody-based products for the applications in immunology, oncology, and infectious diseases. Xcyte Therapies is currently conducting Phase I/II clinical trials in hormone-refractory prostate cancer, multiple myeloma and chronic lymphocytic leukemia.

There are 5 followers

Followers
2
Followers
9
Followers
0
Followers
0
Followers
0